Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

New England Journal of Medicine

Volumn 337, Issue 14, 1997, Pages 956-962

  Ragaz, Joseph ^a   Jackson, Stewart M ^a   Le, Nhu ^a   Plenderleith, Ian H ^a   Spinelli, John J ^b,c   Basco, Vivian E ^a   Wilson, Kenneth S ^a   Knowling, Margaret A ^a   Coppin, Christopher M L ^a   Paradis, Marilyn ^a   Coldman, Andrew J ^a   Olivotto, Ivo A ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; NEOPLASM RECURRENCE, LOCAL; PREMENOPAUSE; RADIOTHERAPY; RECURRENCE; SURVIVAL ANALYSIS;

EID: 0030808429     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199710023371402     Document Type: Article

References (33)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 1995;333:1444-55. [Erratum, N Engl J Med 1996;334: 1003.]
2. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-53.
3. Stjernsward J. Can survival be decreased by post-operative irradiation? Int J Radiat Oncol Biol Phys 1977;2:1171-5.
4. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22:887-96.
5. Fuller SA, Haybittle JL, Smith RE, Dobbs HJ. Cardiac doses in postoperative breast irradiation. Radiother Oncol 1992;25:19-24.
6. Fisher B, Carbone P, Economou SG, et al. l-Phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings. N Engl J Med 1975;292:117-22.
7. Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405-10.
8. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T. Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 1978;41:2088-98.
9. Schabel FM Jr. Concepts for treatment of micrometastases developed in murine systems. AJR Am J Roentgenol 1976;126:500-11.
10. Skipper HE, Schabel FM Jr, Mellett LB, et al. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. Cancer Chemother Rep 1970;54: 431-50.
11. Durand RE. Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment. J Natl Cancer Inst 1986;77:247-52.
12. Tubiana M, Arrigada R, Cosset JM. Sequencing of drugs and radiation: the integrated alternating regimen. Cancer 1985;55:2131-9.
13. Fu KK. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 1985;55:Suppl:2123-30.
14. Vokes EE, Weichselbaum PR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-34. [Erratum, J Clin Oncol 1990;8:1447]
15. Goldie JH, Coldman AJ. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-33.
16. Meakin JW, Alt WEC, Beale FA, et al. Ovarian irradiation and prednisone following surgery for carcinoma of the breast. Can Med Assoc J 1979; 120:1221-9.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
19. Haybittle JL, Brinkley D, Houghton J, A'Hern RP, Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 1989;298:1611-4.
20. Overgaard M, Hansen PS, Rose C, et al. Postmastectomy radiotherapy and adjuvant systemic treatment in high-risk breast cancer patients. Eur J Cancer 1994;30A:Suppl 2:S28. abstract.
21. McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 1986;73:264-6.
22. Muss HB, Cooper MR, Brockschmidt JK, et al. A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer: eleven year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res Treat 1991;19:77-84.
23. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 1987;5:1546-55.
24. Blomqvist C, Tiusanen K, Elomaa I, et al. The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer: long-term follow-up results of a randomised trial. Br J Cancer 1992;66:1171-6.
25. Velez-Garcia E, Carpenter JT Jr, Moore M, et al. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) Trial. Eur J Cancer 1992;28A:1833-7.
26. Buzdar AU, Blumenschein GR, Smith TL, et al. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer: a prospective randomized trial. Cancer 1984;53:384-9.
27. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995;13:2869-78.
28. Fisher B, Redmond C. Lumpectomy for breast cancer: an update of the NSABP experience. In: Consensus Development Conference on the Treatment of Early-Stage Breast Cancer. Journal of the National Cancer Institute monographs. No. 11. Washington, D.C.: Government Printing Office, 1992:7-13. (NIH publication no. 90-3187.)
29. Hermann RE, Esselstyn CB Jr, Grundrest-Broniatowski S, et al. Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breast. Surg Gynecol Obstet 1993;177:247-53.
30. Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992; 84:683-9.
31. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328:1587-91.
32. Marks LB, Halperin EC, Prosnitz LR, et al. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes: Cancer and Leukemia Group B. Int J Radiat Oncol Biol Phys 1992;23:1021-6.
33. Diab SG, deMoor CA, Clark GM, Osborne CK, Ravdin PM, Elledge RM. Radiation therapy improves survival by decreasing local failure in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. Proc Am Soc Clin Oncol 1997;16:130a. abstract.